Reis REIS 深 滬
等待開盤 09-24 09:30:00 美东时间
22.99
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 22.99
- 總市值 2.66亿
- 52周最高 23.81
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 16.085
- 委 比 0.00%
- 總股本 1156.98万
- 歷史最高 26.22
- 量 比 0
- 振 幅 0.00%
- 歷史最低 5.03
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多‘Resident Evil’ drives 28% weekend box-office increase
“Resident Evil” topped the domestic box office with an estimated $60 million opening, helping to lift overall weekend ticket sales by 28% from the prior week, according to a report from Rentrak’s Paul...
09-21 01:30
Acumentis Reissues Compliant AGM Notice After ASX Review
The latest update is out from Acumentis Group Limited ( ($AU:ACU) ). Acumentis ...
09-18 11:27
Trabzonspor Signs Technical Director Thomas Reis on Two‑Year Deal
Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret A.S. ( ($TR:TSPOR) ...
09-17 20:12
Canada Goose CEO Dani Reiss Purchases 100,000 Subordinate Voting Shares On The TSX And Other Canadian Markets
The acquisition increases Mr. Reiss’ ownership position in Canada Goose and reflects his continued long-term investment in the Company. Immediately prior to the acquisition reported hereby, Mr. Reiss beneficially owned and exercised control and direction over 119,413 SVSand, through DTR, 20,130,334 ...
09-10 19:35
国际货币基金组织因候选人针对特朗普关税政策的言论，放弃首席经济学家头号人选
据知情人士透露，国际货币基金组织在最后关头放弃了新任首席经济学家的头号候选人，原因是该候选人曾发表批评特朗普政府经济政策的言论。 这家总部位于华盛顿的机...
09-10 14:26
Ata Turizm Reissues Investor Report Highlighting Global Tourism Scale
An update from Ata Turizm Isletmecilik Tasimacilik Madencilik Kuyumculu ( ($TR:...
09-08 19:43
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
Pasithea Therapeutics Corp. announced that an abstract detailing the Phase 1 dose-escalation study of PAS-004, a next-generation macrocyclic MEK inhibitor, in patients with MAPK pathway-driven advanced solid tumors, has been accepted for poster presentation at the ESMO Congress 2026. The presentation will occur on Friday, October 23, 2026, and the full abstract will be published on the ESMO website under the congress' embargo policy. PAS-004 is b...
07-21 11:00
How does Biogen’s novel Alzheimer’s drug compare to approved drugs
While Biogen (BIIB) traded lower after reporting detailed results from a mid-stage trial for its new Alzheimer’s drug, diranersen, developed with Ionis Pharmaceuticals (IONS), patient advocates were u...
07-14 23:26
DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team
DeFi Development Corp. (DFDV) announced the transition of leadership for DisclaimerCoin (DONT) to Daniel Reis-Faria, CEO of ZeroStack Holdings Inc., and his team. This shift aims to accelerate ecosystem growth, partnerships, and utility for DONT. DFDV and ZeroStack have a prior relationship focused on Solana adoption. Reis-Faria brings extensive blockchain and digital asset experience. DFDV will retain 31.6% of DONT's supply in its treasury, whil...
07-08 13:00
